Income Statement
XOMA Royalty Corp (XOMA)
source: myfinsight.com
Download image
Talphera$28K Tovorafenib-Viracta TherapeuticsInc.$1,715K Affitech ResearchAs-Vabysmo$5,758K Aptevo-Ixinity$249K Revenue from contractswith customers$5,025K Income from purchasedreceivables under the cost...$1,743K Income from purchasedreceivables under the eir...$6,007K Revenue recognizedunder...$354K Total income andrevenues$13,129K Income (loss) fromoperations$4,603K Other income, net$7,824K Total operatingexpenses$8,526K Net income$9,191K Interest expense$3,236K Amortization of intangibleassets$655K General andadministrative$7,802K Research and development$69K